Markets:

Overview

News

Currencies

International

Treasuries

Kamada Ltd. - Ordinary Shares (NQ:KMDA)

7.892 -0.188 (-2.33%)

Delayed Quote Updated: 11:39 AM EDT, Oct 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Kamada Ltd. - Ordinary Shares

< Previous 1 2 3 Next >

Earnings Scheduled For August 17, 2022 ↗

August 17, 2022

Companies Reporting Before The Bell • Children's Place (NASDAQ:PLCE) is expected to report earnings for its second quarter.

Via Benzinga

Kamada's Earnings: A Preview ↗

August 16, 2022

Kamada (NASDAQ:KMDA) is set to give its latest quarterly earnings report on Wednesday, 2022-08-17. Here's what investors need to know before the announcement. Analysts estimate that Kamada will...

Via Benzinga

The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate ↗

July 06, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Recap: Kamada Q1 Earnings ↗

May 17, 2022

Kamada (NASDAQ:KMDA) reported its Q1 earnings results on Tuesday, May 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Kamada: Q4 Earnings Insights ↗

March 15, 2022

Kamada (NASDAQ:KMDA) reported its Q4 earnings results on Tuesday, March 15, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Kamada...

Via Benzinga

Earnings Preview: Kamada ↗

March 14, 2022

Kamada (NASDAQ:KMDA) is set to give its latest quarterly earnings report on Tuesday, 2022-03-15. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Earnings Scheduled For May 17, 2022 ↗

May 17, 2022

Companies Reporting Before The Bell • On Holding (NYSE:ONON) is likely to report earnings for its first quarter.

Via Benzinga

Earnings Preview For Kamada ↗

May 16, 2022

Kamada (NASDAQ:KMDA) is set to give its latest quarterly earnings report on Tuesday, 2022-05-17. Here's what investors need to know before the announcement. Analysts estimate that Kamada will report an...

Via Benzinga

Kamada Stock Jumps After Acquisition Of Four Plasma-Derived Products ↗

November 22, 2021

Kamada Ltd (NASDAQ: KMDA) has acquired four FDA-approved plasma-derived hyperimmune commercial products from Saol Therapeutics. Kamada will pay Saol a $95 million...

Via Benzinga

Kamada: Q3 Earnings Insights ↗

November 22, 2021

Kamada (NASDAQ:KMDA) reported its Q3 earnings results on Monday, November 22, 2021 at 08:00 AM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline ↗

August 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Kamada's Earnings Outlook ↗

August 10, 2021

Kamada (NASDAQ:KMDA) unveils its next round of earnings this Wednesday, August 11. Get prepared with Benzinga's ultimate preview for Kamada's Q2 earnings. Net Income, Earnings,...

Via Benzinga

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal ↗

July 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...

Via Benzinga

Earnings Scheduled For March 15, 2022 ↗

March 15, 2022

Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likely to report quarterly loss at $0.31 per share on revenue of $8.98 million. • Citi...

Via Benzinga

Earnings Scheduled For November 22, 2021 ↗

November 22, 2021

Companies Reporting Before The Bell • Cerence (NASDAQ:CRNC) is estimated to report quarterly earnings at $0.56 per share on revenue of $97.92 million. • Avaya...

Via Benzinga

Kamada's Earnings Outlook ↗

May 11, 2021

On Wednesday, May 12, Kamada (NASDAQ:KMDA) will report its last quarter's earnings. Here is Benzinga's preview of the company's release. Net Income, Earnings, And Earnings Per...

Via Benzinga

Kamada's Earnings: A Preview ↗

November 19, 2021

Kamada (NASDAQ:KMDA) is set to give its latest quarterly earnings report on Monday, 2021-11-22. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology ↗

October 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma ↗

August 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

August 11, 2021

On Wednesday morning, 67 companies achieved new lows for the year. Areas of Significance: Grifols (NASDAQ:GRFS) was the largest firm by market cap to set a new 52-...

Via Benzinga

The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street ↗

July 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated...

Via Benzinga

The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts ↗

May 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc...

Via Benzinga

Earnings Scheduled For May 12, 2021 ↗

May 12, 2021

Companies Reporting Before The Bell • PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter. • Boyd Gaming (NYSE:BYD) is projected to report...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.